Litcius/Paper detail

NTLA-2002: CRISPR/Cas9-mediated gene knockout of KLKB1 to treat hereditary angioedema

Jessica Seitzer

2021Journal of Allergy and Clinical Immunology22 citationsDOI

Topics & Concepts

CRISPRHereditary angioedemaGeneticsGene knockoutGeneBiologyMedicineImmunologyCoagulation, Bradykinin, Polyphosphates, and Angioedema
NTLA-2002: CRISPR/Cas9-mediated gene knockout of KLKB1 to treat hereditary angioedema | Litcius